azacitidine has been researched along with procainamide in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (33.33) | 18.2507 |
| 2000's | 11 (52.38) | 29.6817 |
| 2010's | 3 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Arimondo, PB; Erdmann, A; Fahy, J; Halby, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Hudson, JL; Liebling, MR; Richardson, BC | 1 |
| Hooper, F; O'Rourke, K; Powers, D; Richardson, B; Yung, RL | 1 |
| Chrisp, CE; Johnson, KJ; Quddus, J; Richardson, BC; Yung, RL | 1 |
| Richardson, BC; Yung, RL | 1 |
| Amento, EP; Chrisp, CE; Gavalchin, J; Johnson, KJ; Quddus, J; Richardson, BC; Yung, RL | 1 |
| Deng, C; Hanash, SM; Hemati, N; Richardson, BC; Yang, J | 1 |
| Hibino, Y; Hirose, N; Morita, Y; Ohzeki, H; Sugano, N | 1 |
| Deng, C; Kaplan, MJ; Richardson, BC; Yang, J | 1 |
| Gutsch, D; Kaplan, M; Lu, Q; Ray, D; Richardson, B; Zacharek, S | 1 |
| Acuña, C; Chavez, A; Dueñas-Gonzalez, A; Lizano, M; Mariscal, I; Perez-Cardenas, E; Salazar, AM; Segura-Pacheco, B; Taja-Chayeb, L; Trejo-Becerril, C | 1 |
| Richardson, B | 1 |
| Deng, C; Hanash, S; Lu, Q; Oelke, K; Richardson, B; Richardson, D; Wu, A | 1 |
| Alikhani-Koopaei, R; Fouladkou, F; Frey, BM; Frey, FJ | 1 |
| Jagodzinski, PP; Januchowski, R | 1 |
| Chuang, JC; Jones, PA; Kwan, JM; Li, TW; Liang, G; Yang, AS; Yoo, CB | 1 |
| Meyer, K; Zhang, H; Zhang, L | 1 |
4 review(s) available for azacitidine and procainamide
| Article | Year |
|---|---|
Targeting DNA methylation with small molecules: what's next?
Topics: Animals; Antineoplastic Agents; DNA Methylation; DNA Modification Methylases; Drug Discovery; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Models, Molecular; Molecular Targeted Therapy; Neoplasms; Nucleosides | 2015 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Role of T cell DNA methylation in lupus syndromes.
Topics: Azacitidine; DNA; Humans; Lupus Erythematosus, Systemic; Lymphocyte Function-Associated Antigen-1; Methylation; Procainamide; T-Lymphocytes | 1994 |
DNA methylation and autoimmune disease.
Topics: Animals; Autoimmune Diseases; Autoimmunity; Azacitidine; Cell Communication; DNA Methylation; Humans; Hydralazine; In Vitro Techniques; Lupus Erythematosus, Systemic; Models, Immunological; Procainamide; T-Lymphocytes | 2003 |
17 other study(ies) available for azacitidine and procainamide
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
CD4+ cells treated with DNA methylation inhibitors induce autologous B cell differentiation.
Topics: Acecainide; Antibody Formation; Antigen-Presenting Cells; Antigens, CD; Antigens, Differentiation; Azacitidine; B-Lymphocytes; CD4-Positive T-Lymphocytes; Cell Differentiation; DNA; Histocompatibility Antigens; Humans; Hydroxyurea; Integrin beta1; Leukocyte Common Antigens; Methylation; Procainamide | 1990 |
Lymphocyte function-associated antigen 1 overexpression and T cell autoreactivity.
Topics: Azacitidine; CD18 Antigens; DNA; DNA, Complementary; Humans; Lymphocyte Activation; Lymphocyte Function-Associated Antigen-1; Methylation; Plasmids; Procainamide; T-Lymphocytes; Transfection; Ultraviolet Rays | 1994 |
Mechanism of drug-induced lupus. I. Cloned Th2 cells modified with DNA methylation inhibitors in vitro cause autoimmunity in vivo.
Topics: Animals; Autoantibodies; Azacitidine; Cell Line; Cytokines; Cytotoxicity, Immunologic; DNA; Enzyme-Linked Immunosorbent Assay; Female; Immunoglobulin G; Immunoglobulin M; Immunotherapy, Adoptive; Lupus Erythematosus, Systemic; Lymphocyte Activation; Methylation; Mice; Mice, Inbred AKR; Mice, Inbred NZB; Procainamide; Th2 Cells | 1995 |
Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice.
Topics: Animals; Antigen-Presenting Cells; Azacitidine; CD4-Positive T-Lymphocytes; DNA (Cytosine-5-)-Methyltransferases; Female; Immunization, Passive; Lupus Erythematosus, Systemic; Lymphocyte Activation; Mice; Mice, Inbred DBA; Procainamide | 1993 |
Effect of mitogenic stimulation and DNA methylation on human T cell DNA methyltransferase expression and activity.
Topics: Adult; Azacitidine; DNA Methylation; DNA-Cytosine Methylases; Enzyme Activation; Humans; Jurkat Cells; Lymphocyte Activation; Male; Phytohemagglutinins; Procainamide; RNA, Messenger; T-Lymphocytes; Transcription, Genetic | 1997 |
Involvement of DNA methylation in binding of a highly repetitive DNA component to nuclear scaffold proteins from rat liver.
Topics: Animals; Antigens, Nuclear; Azacitidine; Cell Line; CpG Islands; Decitabine; DNA; DNA Methylation; DNA-Binding Proteins; Gene Expression Regulation; Liver; Nuclear Proteins; Procainamide; Protein Binding; Rats; Repetitive Sequences, Nucleic Acid | 1998 |
DNA methylation in the regulation of T cell LFA-1 expression.
Topics: Azacitidine; Cell Line, Transformed; DNA Methylation; Enzyme Inhibitors; Gene Expression Regulation; Humans; Jurkat Cells; Lymphocyte Function-Associated Antigen-1; Procainamide; Promoter Regions, Genetic; T-Lymphocytes; Transcription, Genetic | 2000 |
Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus.
Topics: Adult; Autoimmunity; Azacitidine; Cells, Cultured; DNA Methylation; Enzyme Inhibitors; Female; Gene Expression; Humans; Lupus Erythematosus, Systemic; Lymphocyte Function-Associated Antigen-1; Male; Middle Aged; Platelet Aggregation Inhibitors; Procainamide; Promoter Regions, Genetic; T-Lymphocytes | 2002 |
Reactivation of tumor suppressor genes by the cardiovascular drugs hydralazine and procainamide and their potential use in cancer therapy.
Topics: Animals; Antimetabolites, Antineoplastic; Azacitidine; Breast Neoplasms; Cell Cycle; Cyclin-Dependent Kinase Inhibitor p16; Decitabine; DNA Methylation; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Head and Neck Neoplasms; Humans; Hydralazine; Mice; Mice, Nude; Procainamide; Receptors, Estrogen; Receptors, Retinoic Acid; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 2003 |
Overexpression of CD70 and overstimulation of IgG synthesis by lupus T cells and T cells treated with DNA methylation inhibitors.
Topics: Adult; Aged; Antigens, CD; Azacitidine; B-Lymphocytes; CD27 Ligand; DNA Methylation; Enzyme Inhibitors; Female; Gene Expression; Humans; Immunoglobulin G; Lupus Erythematosus, Systemic; Male; Membrane Proteins; Middle Aged; Oligonucleotide Array Sequence Analysis; Platelet Aggregation Inhibitors; Procainamide; T-Lymphocytes | 2004 |
Epigenetic regulation of 11 beta-hydroxysteroid dehydrogenase type 2 expression.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Animals; Azacitidine; Base Sequence; Blood Pressure; Cell Line, Tumor; CpG Islands; Decitabine; DNA; DNA Methylation; Enzyme Inhibitors; Epigenesis, Genetic; Humans; Hydrocortisone; Hydroxamic Acids; Hypertension; Molecular Sequence Data; Procainamide; Promoter Regions, Genetic; Rats; Rats, Wistar; Receptors, Glucocorticoid; Transcription Factors; Transcription, Genetic | 2004 |
Effect of 5-azacytidine and procainamide on CD3-zeta chain expression in Jurkat T cells.
Topics: Anti-Arrhythmia Agents; Azacitidine; CD3 Complex; Enzyme Inhibitors; Flow Cytometry; Humans; Jurkat Cells; Polymerase Chain Reaction; Procainamide; Repressor Proteins; RNA, Messenger; Tumor Cells, Cultured | 2005 |
Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2'-deoxycytidine.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Carcinoma, Transitional Cell; Catechin; Cell Line, Tumor; Colorectal Neoplasms; Cytidine; Decitabine; Deoxycytidine; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Female; Gene Silencing; HT29 Cells; Humans; Hydralazine; Male; Procainamide; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction | 2005 |
Direct effect of cocaine on epigenetic regulation of PKCepsilon gene repression in the fetal rat heart.
Topics: Animals; Azacitidine; Base Sequence; Binding Sites; Cocaine; DNA Methylation; Enzyme Repression; Epigenesis, Genetic; Female; Fetus; Molecular Sequence Data; Mutation; Myocardium; Pregnancy; Procainamide; Promoter Regions, Genetic; Protein Binding; Protein Kinase C-epsilon; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sp1 Transcription Factor | 2009 |